References
- Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593−615, 2001 https://doi.org/10.1042/0264-6021:3570593
- Baker H, Farbman AI. Olfactory afferent regulation of the dopamine phenotype in the fetal rat olfactory system. Neuroscience 52: 115−134, 1993 https://doi.org/10.1016/0306-4522(93)90187-K
- Boer R UMPW, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58: 1026−1034, 2000
- Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 8: 3−11, 1992 https://doi.org/10.1016/0896-6273(92)90104-L
- Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport 4: 444−446, 1993a https://doi.org/10.1097/00001756-199304000-00027
- Buisson A, Margaill I, Callebert J, Plotkine M, Boulu RG. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J Neurochem 61: 690−696, 1993b https://doi.org/10.1111/j.1471-4159.1993.tb02174.x
- Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623−634, 1988 https://doi.org/10.1016/0896-6273(88)90162-6
- Ciani E, Baldinotti I, Contestabile A. Sustained, long-lasting inhibition of nitric oxide synthase aggravates the neural damage in some models of excitotoxic brain injury. Brain Res Bull 56: 29−35, 2001 https://doi.org/10.1016/S0361-9230(01)00589-5
- Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689−695, 1993 https://doi.org/10.1126/science.7901908
- Danielisova V, Nemethova M, Burda J. The protective effect of aminoguanidine on cerebral ischemic damage in the rat brain. Physiol Res 53: 533−540, 2004
- Du W, Harvey JA. The nitric oxide synthesis inhibitor L-NAME facilitates associative learning. Prog Neuropsychopharmacol Biol Psychiatry 20: 1183−1195, 1996 https://doi.org/10.1016/S0278-5846(96)00105-4
- Du W, Weiss H, Harvey JA. Associative learning is enhanced by selective neuronal nitric oxide synthase inhibitors and retarded by a nitric oxide donor in the rabbit. Psychopharmacology (Berl) 150: 264−271, 2000 https://doi.org/10.1007/s002130000412
- Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57: 683−706, 1995 https://doi.org/10.1146/annurev.ph.57.030195.003343
- Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57: 737−769, 1995 https://doi.org/10.1146/annurev.ph.57.030195.003513
- Haberny KA, Pou S, Eccles CU. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci Lett 146: 187−190, 1992 https://doi.org/10.1016/0304-3940(92)90074-H
- Henshall DC, Bonislawski DP, Skradski SL, Araki T, Lan JQ, Schindler CK, Meller R, Simon RP. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ 8: 1169−1181, 2001 https://doi.org/10.1038/sj.cdd.4400921
- Jones PA, Smith RA, Stone TW. Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity. Neurosci Lett 249: 75−78, 1998 https://doi.org/10.1016/S0304-3940(98)00372-3
- Kiedrowski L, Costa E, Wroblewski JT. Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J Neurochem 58: 335−341, 1992 https://doi.org/10.1111/j.1471-4159.1992.tb09315.x
- Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84: 253−256, 1999 https://doi.org/10.1161/01.RES.84.3.253
- Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 90: 3024−3027, 1993 https://doi.org/10.1073/pnas.90.7.3024
- Laursen SE, Belknap JK. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16: 355−357, 1986 https://doi.org/10.1016/0160-5402(86)90038-0
- Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 399: A7−14, 1999 https://doi.org/10.1038/399a007
- McNamara JO. Emerging insights into the genesis of epilepsy. Nature 399: A15−22, 1999 https://doi.org/10.1038/399a015
- Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 49: 137−142, 1997
- Mulsch A, Busse R, Mordvintcev PI, Vanin AF, Nielsen EO, Scheel-Kruger J, Olesen SP. Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport 5: 2325−2328, 1994 https://doi.org/10.1097/00001756-199411000-00029
- Penix LP, Davis W, Subramaniam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res 18: 177−184, 1994 https://doi.org/10.1016/0920-1211(94)90038-8
- Perez-Asensio FJ, Hurtado O, Burguete MC, Moro MA, Salom JB, Lizasoain I, Torregrosa G, Leza JC, Alborch E, Castillo J, Knowles RG, Lorenzo P. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis 18: 375−384, 2005 https://doi.org/10.1016/j.nbd.2004.10.018
- Rondouin G, Bockaert J, Lerner-Natoli M. L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. Neuroreport 4: 1187−1190, 1993
- Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 15: 8419−8429, 1995
- Shapira S, Kadar T, Weissman BA. Dose-dependent effect of nitric oxide synthase inhibition following transient forebrain ischemia in gerbils. Brain Res 668: 80−84, 1994 https://doi.org/10.1016/0006-8993(94)90513-4
- Southam E, Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32: 1267−1277, 1993 https://doi.org/10.1016/0028-3908(93)90021-T
- Starr MS, Starr BS. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol Biochem Behav 45: 321−325, 1993 https://doi.org/10.1016/0091-3057(93)90246-P
- Sugimoto K, Iadecola C. Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci Lett 331: 25−28, 2002 https://doi.org/10.1016/S0304-3940(02)00834-0
- Takei Y, Takashima S, Ohyu J, Matsuura K, Katoh N, Takami T, Miyajima T, Hoshika A. Different effects between 7-nitroindazole and L-NAME on cerebral hemodynamics and hippocampal lesions during kainic acid-induced seizures in newborn rabbits. Brain Dev 23: 406−413, 2001 https://doi.org/10.1016/S0387-7604(01)00253-4
- Takei Y, Takashima S, Ohyu J, Takami T, Miyajima T, Hoshika A. Effects of nitric oxide synthase inhibition on the cerebral circulation and brain damage during kainic acid-induced seizures in newborn rabbits. Brain Dev 21: 253−259, 1999 https://doi.org/10.1016/S0387-7604(99)00019-4
- Tsuda M, Suzuki T, Misawa M. Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice. Life Sci 60: 339−343, 1997 https://doi.org/10.1016/S0024-3205(97)00226-9
- Yamamoto S, Golanov EV, Berger SB, Reis DJ. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 12: 717−726, 1992 https://doi.org/10.1038/jcbfm.1992.102